Details for 2012160493

Up to date per 04.04.2026

Actions

Title / Product Name

Kristalline Formen von 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluormethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamidsulfat und seine amorphe Form

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012160493

EP Publication Number

2535337

E-Number

921197

Language

PCT Number

Publication Date

19.12.2012 A

23.08.2017 B1

Registration Date

23.08.2017

AT Publication Date

15.09.2017

Application Date

18.07.2006

Registration Number

Priorities

20.07.2005

701405 P

12.09.2005

716214 P

IPC

C07D 401/14 20060101AFI20121109BHEP

Maximum Duration of Protection

18.07.2026

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Novartis Pharma GmbHBrunner Strasse 59 1230 WienAT

Representative

No representatives present

Inventor

Manley, Paul W.Bruggweg 12 4144 ArlesheimCH

Shieh, Wen-Chung295 TimberDrive Berkeley Heights, NJ 07922US

Sutton, Paul Allen34 Irvington Road Parsippany, NJ 07054US

Karpinski, Piotr H.25 Terrace Parkway Lincoln Park, NJ 07035US

Wu, Raeann2423 Rachel Terrace Pine Brook, NJ 07058US

Monnier, Stéphanie6, Le Parc 68190 RaedersheimFR

Brozio, JörgSpalentorweg 20 4051 BaselCH